Treading the beaten path with old and new obstacles: a report from the Indian HIPEC registry

References

• Chia CS, You B, Decullier E, et al. Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility? Ann Surg Oncol. 2016;23:1971–1979.
   PubMed Web of Science ®Google Scholar
• Goéré D, Malka D, Tzanis D, et al. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg. 2013;257:1065–1071.
   PubMed Web of Science ®Google Scholar
• Baratti D, Kusamura S, Cabras AD, et al. Diffuse malignant peritoneal mesothelioma: Long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Cancer. 2013;49:3140–3148.
   PubMed Web of Science ®Google Scholar
• Moran BJ. Decision-making and technical factors account for the learning curve in complex surgery. J Public Health (Oxf). 2006;28:375–378.
   PubMed Web of Science ®Google Scholar
• Bhatt A, Mehta S, Seshadri RA, et al. The initial Indian experience with cytoreductive surgery and HIPEC in the treatment of peritoneal metastases. Indian J Surg Oncol. 2016;7:160–165.
   PubMed Web of Science ®Google Scholar
• Chang KH, Kazanowski M, Staunton O, et al. Mentored experience of establishing a national peritoneal malignancy programme—experience of first 50 operative cases. Eur J Surg Oncol. 2017;43:395–400.
   PubMed Web of Science ®Google Scholar
• Verwaal VJ, Rau B, Jamali F, et al. Registries on peritoneal surface malignancies throughout the world, their use and their options. Int J Hyperthermia. 2017;33:528–533.
   PubMed Web of Science ®Google Scholar
• Villeneuve L, Passot G, Glehen O, et al. The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry. Orphanet J Rare Dis. 2017;12:37.
   PubMed Web of Science ®Google Scholar
• Maillet M, Glehen O, Lambert J, et al. Early postoperative chemotherapy after complete cytoreduction and hyperthermic intraperitoneal chemo- therapy for isolated peritoneal carcinomatosis of colon cancer: a multicenter study. Ann Surg Oncol. 2016;23:863–869.
   PubMed Web of Science ®Google Scholar
• Razenberg LG, van Gestel YR, Creemers GJ, et al. Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment 905 of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands. Eur J Surg Oncol. 2015;41:466–471.
   PubMed Web of Science ®Google Scholar
• Pramesh CS, Badwe RA, Borthakur BB, et al. Delivery of affordable and equitable cancer care in India. Lancet Oncol. 2014;15:e223–e233.
   PubMed Web of Science ®Google Scholar
• Bhatt A, Mehta S, Ramakrishnan AS, et al. Setting up of the Indian HIPEC registry: a registry for Indian patients with peritoneal surface malignancies. Indian J Surg Oncol. 2017;8:527–532.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH, Van der Speeten K, Stuart OA, et al. Patient- and treatment related variables, adverse events and their statistical relationship for treatment of peritoneal metastases. In: Sugarbaker PH, editor. Cytoreductive surgery & perioperative chemotherapy for peritoneal surface malignancy: textbook and video atlas. Woodbury: Ciné-Med; 2012.
   Google Scholar
• Pelz JO. Peritoneal carcinomatosis: registry and centers in Germany. Viszeralmedizin. 2013;29:3–229.
   Google Scholar
• Sugarbaker PH. The Seven Best from PSOGI 2016. Ann Surg Oncol. 2017;24:870–874.
   PubMed Web of Science ®Google Scholar
• Sullivan R, Badwe RA, Rath GK, et al. Cancer research in India: national priorities, global results. Lancet Oncol. 2014;15:e213–e222.
   PubMed Web of Science ®Google Scholar
• Bhandare M, Patil P, Pai V, et al. Peritoneal carcinomatosis in colorectal cancers—management perspective needs a change. Clin Colorectal Cancer. 2017;16:e1–e6.
   PubMed Web of Science ®Google Scholar
• Chua TC, Moran BJ, Sugarbaker PH, et al. Early and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449–2456.
   PubMed Web of Science ®Google Scholar
• Levine EA, Stewart JH, Shen P, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 Patients. J Am Coll Surg. 2014;218:573–585.
   PubMed Web of Science ®Google Scholar
• Passot G, Vaudoyer D, Villeneuve L, et al. What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1,125 procedures. J Surg Oncol. 2016;113:796–803.
   PubMed Web of Science ®Google Scholar
• Pinar U, Tremblay JF, Passot G, et al. Reconstruction after ureteral resection during HIPEC surgery: re-implantation with uretero-neocystostomy seems safer than end-to-end anastomosis. J Visc Surg. 2017;154:227–230.
   PubMed Web of Science ®Google Scholar
• Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681–685.
   PubMed Web of Science ®Google Scholar
• Ihemelandu C, Sugarbaker PH. Management for peritoneal metastasis of colonic origin: role of cytoreductive surgery and perioperative Intraperitoneal chemotherapy: a single Institution’s experience during two decades. Ann Surg Oncol. 2017;24:898–905.
   PubMed Web of Science ®Google Scholar
• Brandl A, Weiss S, von Winterfeld M, et al. Predictive value of peritoneal cancer index for survival in patients with mucinous peritoneal malignancies treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience. Int J Hyperthermia. 2018;34:512–517.
   PubMed Web of Science ®Google Scholar
• Enblad M, Ghanipour L, Cashin PH. Prognostic scores for colorectal cancer with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperthermia. 2018;1–6.
   Web of Science ®Google Scholar
• Di Giorgio A, De Iaco P, De Simone M, et al. Cytoreduction (peritonectomy procedures) combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in advanced ovarian cancer: retrospective Italian multicenter observational study of 511 cases. Ann Surg Oncol. 2017;24:914–922.
   PubMed Web of Science ®Google Scholar
• Arjona-Sanchez A, Rufián-Peña S. Progress in the management of primary and recurrent ovarian carcinomatosis with peritonectomy procedure and HIPEC in a high volume centre. Int J Hyperthermia. 2017;33:554–561.
   PubMed Web of Science ®Google Scholar
• Bhatt A, Prabhu R, Sethna K, et al. The “homemade” HIPEC machine—a cost-effective alternative in low-resource countries. Pleura and Peritoneum. 2017;2:163–170.
   PubMed Web of Science ®Google Scholar
• Alyami M, Kim BJ, Villeneuve L, et al. Ninety-day post-operative morbidity and mortality using the National Cancer Institute’s common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperthermia. 2018;34: 532–537.
   PubMed Web of Science ®Google Scholar
• Pramesh CS, Badwe RA, Sinha RK. The National Cancer Grid of India. Indian J Med Paediatr Oncol. 2014;35:226–227.
   PubMedGoogle Scholar
• Gupta N, Asif S, Gandhi J, Rajpurohit S, et al. Role of CRS and HIPEC in appendiceal and colorectal malignancies: Indian experience. Indian J Gastroenterol. 2017;36:126–130.
   PubMed Web of Science ®Google Scholar
• National Cancer Registry Programme. (2015) WWW page. URL: http://ncrpindia.org. Last accessed 2018 Feb 27.
   Google Scholar
• Li Y, Zhou Y-F, Liang H, et al. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies. WJG. 2016;22:6906–6916.
   PubMed Web of Science ®Google Scholar
• Batista PB, Sarmento BJQ, Loureiro FL, et al. A proposal of Brazilian Society of Surgical Oncology (BSSO/SBCO) for standardizing cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in Brazil: pseudomixoma peritonei, appendiceal tumors and malignant peritoneal mesothelioma. Rev Col Bras Cir. 2017;44:530–544.
   PubMedGoogle Scholar